IOL CHEMICALS & PHARM. | SANOFI INDIA | IOL CHEMICALS & PHARM./ SANOFI INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | 31.0 | 39.9% | View Chart |
P/BV | x | 1.4 | 15.4 | 9.1% | View Chart |
Dividend Yield | % | 1.1 | 7.0 | 15.8% |
IOL CHEMICALS & PHARM. SANOFI INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SANOFI INDIA Dec-22 |
IOL CHEMICALS & PHARM./ SANOFI INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 7,939 | 6.8% | |
Low | Rs | 272 | 5,454 | 5.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 1,202.8 | 31.4% | |
Earnings per share (Unadj.) | Rs | 23.7 | 269.5 | 8.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 287.7 | 11.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 570.00 | 0.7% | |
Avg Dividend yield | % | 1.0 | 8.5 | 11.6% | |
Book value per share (Unadj.) | Rs | 256.8 | 527.0 | 48.7% | |
Shares outstanding (eoy) | m | 58.71 | 23.03 | 254.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 5.6 | 19.2% | |
Avg P/E ratio | x | 17.1 | 24.9 | 68.7% | |
P/CF ratio (eoy) | x | 12.8 | 23.3 | 55.0% | |
Price / Book Value ratio | x | 1.6 | 12.7 | 12.4% | |
Dividend payout | % | 16.9 | 211.5 | 8.0% | |
Avg Mkt Cap | Rs m | 23,743 | 154,224 | 15.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 4,059 | 41.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 27,701 | 80.0% | |
Other income | Rs m | 256 | 730 | 35.1% | |
Total revenues | Rs m | 22,427 | 28,431 | 78.9% | |
Gross profit | Rs m | 2,257 | 8,349 | 27.0% | |
Depreciation | Rs m | 462 | 419 | 110.2% | |
Interest | Rs m | 165 | 17 | 968.8% | |
Profit before tax | Rs m | 1,887 | 8,643 | 21.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 2,437 | 20.3% | |
Profit after tax | Rs m | 1,391 | 6,206 | 22.4% | |
Gross profit margin | % | 10.2 | 30.1 | 33.8% | |
Effective tax rate | % | 26.2 | 28.2 | 93.1% | |
Net profit margin | % | 6.3 | 22.4 | 28.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 36,121 | 26.8% | |
Current liabilities | Rs m | 5,025 | 27,425 | 18.3% | |
Net working cap to sales | % | 20.9 | 31.4 | 66.7% | |
Current ratio | x | 1.9 | 1.3 | 146.1% | |
Inventory Days | Days | 43 | 117 | 37.1% | |
Debtors Days | Days | 8 | 17 | 48.9% | |
Net fixed assets | Rs m | 11,017 | 12,148 | 90.7% | |
Share capital | Rs m | 587 | 230 | 255.3% | |
"Free" reserves | Rs m | 14,490 | 11,906 | 121.7% | |
Net worth | Rs m | 15,077 | 12,136 | 124.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 48,279 | 42.8% | |
Interest coverage | x | 12.5 | 509.4 | 2.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.6 | 186.8% | |
Return on assets | % | 7.5 | 12.9 | 58.4% | |
Return on equity | % | 9.2 | 51.1 | 18.0% | |
Return on capital | % | 13.6 | 71.4 | 19.1% | |
Exports to sales | % | 26.7 | 14.1 | 189.8% | |
Imports to sales | % | 0 | 14.6 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 3,904 | 151.9% | |
Imports (cif) | Rs m | NA | 4,037 | 0.0% | |
Fx inflow | Rs m | 5,930 | 3,904 | 151.9% | |
Fx outflow | Rs m | 6,052 | 4,037 | 149.9% | |
Net fx | Rs m | -122 | -133 | 91.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 3,987 | 30.7% | |
From Investments | Rs m | -1,200 | 6,509 | -18.4% | |
From Financial Activity | Rs m | -41 | -15,827 | 0.3% | |
Net Cashflow | Rs m | -18 | -5,331 | 0.3% |
Indian Promoters | % | 48.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 60.4 | - | |
Indian inst/Mut Fund | % | 2.5 | 28.8 | 8.8% | |
FIIs | % | 2.2 | 6.3 | 34.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 39.6 | 130.8% | |
Shareholders | 134,235 | 62,870 | 213.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: SUN PHARMA CIPLA DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Sanofi India | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | 2.06% | 1.18% |
1-Month | -9.26% | -8.09% | -0.75% |
1-Year | 29.97% | 44.45% | 61.82% |
3-Year CAGR | -13.41% | 0.97% | 18.16% |
5-Year CAGR | 13.41% | 7.07% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Sanofi India share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Sanofi India the stake stands at 60.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Sanofi India.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Sanofi India paid Rs 570.0, and its dividend payout ratio stood at 211.5%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Sanofi India.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.